Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibiotic Treatment in Children With Urinary Tract Infections
NCT00161330Phase 3Terminated
- Sponsor
- Università di Padova
- Start
- Jun 2000
- Modality
- Reversible Covalent Inhibitors
01
Overview
Phase 3, randomised, open-label trial of amoxicillin + clavulanate and ceftriaxone in urinary tract infection (UTI) (2 arms), sponsored by Università di Padova. Primary endpoints: Duration of fever (>38°C), Sterilization of the urine and 2 more. Started Jun 2000; status: terminated.
02
Drugs
amoxicillin + clavulanateceftriaxone
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on NCT00161330.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00161330.